InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Engelson Erik T., 董事长兼首席执行官. Insider active across 1 company, notably Lucira Health, Inc.. In total, 4 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €133k. Activity tracked since 15 March 2022. The latest transaction was filed on 3 March 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Engelson Erik T. is President and Chief Executive at Lucira Health, Inc. (XNAS). He has 4 filings in total, and the sampled recent filings, from 2022-03-16 to 2023-03-13, show EUR 132813 of purchases and EUR 0 of sales, with the modal transaction nature listed as Acquisition.